Anja Rinke

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Medicine, Oncology, Pharmacotherapy +17

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms

Maximilian Heetfeld, C. Chougnet, Ingrid Holst Olsen et al. · Endocrine Related Cancer · 2015 · 388 citations · Full text

Medicine, Oncology, Surgery +17

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival

Anja Rinke, Michael Wittenberg, Carmen Schade‐Brittinger et al. · Neuroendocrinology · 2016 · 384 citations

Medicine, Oncology, Pharmacology +17

Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial

Rudolf Arnold, Anja Rinke, Klaus‐Jochen Klose et al. · Clinical Gastroenterology and Hepatology · 2005 · 252 citations · Full text

Medicine, Endocrinology, Oncology +13

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Gregory Kaltsas, Martyn Caplin, Philippa Davies et al. · Neuroendocrinology · 2017 · 201 citations · Full text

Medicine, Perioperative Medicine, Surgery +17